Tirzepatide.
Tirzepatide is a GIP/GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism.
Subcutaneous injection in 6 concentration tiers; available with B12 or glycine. Sublingual form also available.Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Who it’s best for:
- Adults with type 2 diabetes to improve glycemic control and lower HbA1c, often with the added benefit of substantial weight loss
- Adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27)
- People with moderate to severe obstructive sleep apnea who also have obesity
- Individuals seeking 15–20%+ average body weight reduction along with better insulin sensitivity and metabolic health
This isn't for you if
Provider review is required. Treatment is prescribed only when clinically appropriate.
Tirzepatide
Tirzepatide is a GIP/GLP-1 receptor agonist and offers advanced therapy that help regulate appetite, blood sugar, and metabolism. This is why dual therapies often works better then GLP-1 alone. Available in 6 subcutaneous concentrations. injectable form comes with your chocie of B12 or glycine combinations. Also, available is sublingual form (under-the-tongue).
Mechanism and fit.
How it works:
Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two natural gut hormones to regulate blood sugar and appetite.
It works by stimulating glucose-dependent insulin release from the pancreas while suppressing glucagon, which lowers blood glucose levels safely. It also slows gastric emptying (food stays in the stomach longer) and acts on the brain to reduce hunger, increase satiety, and decrease overall calorie intake. The added GIP component enhances insulin sensitivity, improves fat metabolism, and amplifies the appetite-suppressing effects beyond what single GLP-1 drugs like semaglutide achieve alone.
This formulation pairs tirzepatide's dual-action metabolic support with the energy-boosting benefits of Vitamin B12. Tirzepatide activates both GLP-1 and GIP receptors to reduce appetite and improve metabolic function, while B12 helps maintain energy levels and support overall wellbeing throughout your weight loss journey. Administered as a subcutaneous injection and prescribed by a licensed provider, this combination is tailored to your individual health profile.
Who this is typically for.
- Who it’s best for:
- Adults with type 2 diabetes to improve glycemic control and lower HbA1c, often with the added benefit of substantial weight loss
- Adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27)
- People with moderate to severe obstructive sleep apnea who also have obesity
- Individuals seeking 15–20%+ average body weight reduction along with better insulin sensitivity and metabolic health
What patients
most often ask.
Why does tirzepatide often produce more weight loss than semaglutide?
Tirzepatide activates two receptors (GIP and GLP-1) instead of one, which amplifies appetite suppression, slows gastric emptying, and improves insulin sensitivity. Clinical data show greater average weight loss with tirzepatide than with semaglutide.
Is the side-effect profile different from semaglutide?
The types of side effects are similar (mostly GI), but tirzepatide may produce stronger early effects in some patients because of its dual mechanism. Slow titration helps.
Do I need labs before starting?
Yes — baseline HbA1c, lipids, kidney function, and thyroid panel are typically required. Your provider may order additional tests based on your history.
Can I switch from semaglutide to tirzepatide?
Yes, many patients do. Your provider will guide the transition and starting dose based on your prior therapy.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Who it’s best for:</li><li>Adults with type 2 diabetes to improve glycemic control and lower HbA1c, often with the added benefit of substantial weight loss</li><li>Adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27)</li><li>People with moderate to severe obstructive sleep apnea who also have obesity</li><li>Individuals seeking 15–20%+ average body weight reduction along with better insulin sensitivity and metabolic health</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering Tirzepatide, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.